[BOOK][B] Scaling up health service delivery: from pilot innovations to policies and programmes
R Simmons, P Fajans, L Ghiron - 2007 - books.google.com
This book considers the topic of scaling up from a particular vantage point. The focus is on
ways to increase the impact of health service innovations that have been tested in pilot or …
ways to increase the impact of health service innovations that have been tested in pilot or …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
…, C Gower, E Gallagher, R Simmons… - The New England …, 2021 - ncbi.nlm.nih.gov
Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
[HTML][HTML] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort …
…, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons… - The Lancet, 2021 - thelancet.com
Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to …
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to …
Women's fears and men's anxieties: the impact of family planning on gender relations in northern Ghana
The Navrongo experiment, a family planning and health project in northern Ghana, has
demonstrated that an appropriately designed, community‐based family planning program can …
demonstrated that an appropriately designed, community‐based family planning program can …
Beyond supply: the importance of female family planning workers in rural Bangladesh
R Simmons, L Baqee, MA Koenig, JF Phillips - Studies in family planning, 1988 - JSTOR
Using participant observation data on worker-client exchanges from Bangladesh, this article
examines the interface between a government family planning program and the rural …
examines the interface between a government family planning program and the rural …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
…, C Gower, E Gallagher, R Simmons… - … England Journal of …, 2021 - Mass Medical Soc
Background The B.1.617.2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England …
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the …
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the …
[HTML][HTML] Duration of protection against mild and severe disease by Covid-19 vaccines
…, C Gower, F Kirsebom, R Simmons… - … England Journal of …, 2022 - Mass Medical Soc
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
[HTML][HTML] Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study
…, N Rojas, K McOwat, R Simmons… - The Lancet Child & …, 2022 - thelancet.com
Background We describe post-COVID symptomatology in a non-hospitalised, national sample
of adolescents aged 11–17 years with PCR-confirmed SARS-CoV-2 infection compared …
of adolescents aged 11–17 years with PCR-confirmed SARS-CoV-2 infection compared …
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and …
Objectives To estimate the real-world effectiveness of the Pfizer/BioNTech BNT162b2 vaccine
and Astrazeneca ChAdOx1 vaccine against Confirmed COVID-19, hospitalisations and …
and Astrazeneca ChAdOx1 vaccine against Confirmed COVID-19, hospitalisations and …
